Canntab Therapeutics Limited
PILL
Rang in aandelen
#40490
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Aandeelprijs
$0.0036163
Laatst gesynchroniseerd: 2023-10-30
Marktkapitalisatie
$118.21K
Verandering (1 dag)
0.39%
Verandering (1 jaar)
3,516.30%
Land
CA
Handel Canntab Therapeutics Limited (PILL)
Categorie
Healthcare
Koersgeschiedenis voor Canntab Therapeutics Limited (PILL)
Hoogste slotkoers: $0.00 op 2025-11-01
Laagste slotkoers: $6.44 op 2017-11-01
Laagste slotkoers: $6.44 op 2017-11-01
Koersgeschiedenis van Canntab Therapeutics Limited van 2017 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | 0.00% |
| 2024 | -98.51% |
| 2023 | -50.94% |
| 2022 | -97.46% |
| 2021 | -12.65% |
| 2020 | 80.79% |
| 2019 | -53.66% |
| 2018 | -94.67% |
| 2017 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $18.40 | -4.21% |
IN
|
